David Clair | executive |
Charles Kummeth | executive |
James Hippel | executive |
Puneet Souda | analyst |
Kim Kelderman | executive |
Daniel Arias | analyst |
Patrick Donnelly | analyst |
Thomas Peterson | analyst |
Matthew Larew | analyst |
Alexander Nowak | analyst |
Paul Knight | analyst |
Justin Bowers | analyst |
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2024. [Operator Instructions] I would now like to turn the call over to David Clair, Bio-Techne's Vice President, Investor Relations.
Good morning, and thank you for joining us.
On the call with me this morning are Chuck Kummeth, Bio-Techne's Chief Executive Officer; Jim Hippel, Chief Financial Officer; and Kim Kelderman, Chief Operating Officer.
Before we begin, let me briefly cover our safe harbor statement.